For Ayurvedic manufacturers, distributors and institutional buyers, regulatory compliance is an important part of responsible sourcing. In Kerala, the Ayurveda Drugs Control wing of the State Drugs Control Department, under the Health and Family Welfare Department, oversees the manufacture of Ayurveda, Siddha and Unani (ASU) medicines intended for sale.
Its responsibilities include licensing, inspections, drug sampling, laboratory analysis, complaint investigation and enforcement.
1. Manufacturing and Loan Licences
Manufacturers must obtain the appropriate licence or loan licence and meet applicable requirements for infrastructure, technical personnel and Schedule T compliance.
For B2B buyers, checking the validity and relevance of a manufacturer's licence should be part of the initial supplier evaluation. For established Ayurvedic manufacturers such as Kairali products, maintaining the required regulatory documentation is an important part of responsible manufacturing and supply.
2. GMP Certification
Good Manufacturing Practice (GMP) certification is another important part of the regulatory framework. The Kerala Health Department provides GMP certification for eligible ASU manufacturers, subject to renewal requirements.
GMP reflects compliance with specified manufacturing practices, but it should be considered alongside other quality and documentation checks when evaluating a supplier.
3. Ongoing Licence Compliance
Regulatory compliance does not end once a manufacturing licence is issued. The Kerala Health Department specifies continuing requirements for licence retention, including annual compliance declarations.
This makes periodic supplier-documentation reviews important for distributors and institutional buyers working with manufacturers such as Kairali Products.
4. Testing and Quality Documentation
Testing laboratories involved with ASU medicines are also subject to regulatory approval and renewal requirements.
For buyers, understanding a manufacturer's testing processes, batch records, quality documentation and traceability can provide useful insight into its quality-control practices.
5. Export Documentation
Free Sale and Non-Conviction Certificates are among the regulatory services available through the department. These documents can be relevant to manufacturers and exporters working with international distributors.
For companies such as Kairali Products serving wider markets, export documentation can form an important part of supplier and market-entry due diligence. However, overseas buyers must also consider the specific regulatory requirements of their destination country.
6. Advertising Compliance
The regulatory framework also extends to advertising. The Kerala Health Department requires applicable approval for advertisements relating to ASU products.
For Ayurvedic companies, responsible product communication is therefore part of compliance. Marketing claims should be handled carefully and within the applicable regulatory requirements.
What Should B2B Buyers Check?
When evaluating an Ayurvedic manufacturer, buyers can consider a few basic questions:
- Is the manufacturing licence current?
- Is applicable GMP certification valid?
- Are testing and batch records properly maintained?
- Is relevant export documentation available?
- Are product claims and advertising handled appropriately?
- Does the supplier meet the requirements of the destination market?
These checks do not replace detailed regulatory due diligence, but they provide a useful starting point when assessing suppliers such as Kairali.
Regulation as Part of Ayurveda’s Credibility
As Ayurveda continues to expand into international markets, quality and regulatory discipline are becoming increasingly important alongside traditional knowledge and product demand.
For manufacturers and B2B buyers, understanding Kerala's Ayurveda drug-control framework provides useful context for evaluating suppliers, documentation and quality systems. For Kairali and other established Ayurvedic businesses, such frameworks are part of building transparent and responsible long-term supply relationships.

No comments:
Post a Comment